eConsent is imperative for continuing research during the COVID-19 pandemic and beyond, but regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 12 countries on use of eSignature and eConsent in clinical trials.
Countries covered:
- Australia
- Belgium
- Canada
- France
- Germany
- Israel
- Italy
- Japan
- Netherlands
- Spain
- United Kingdom
- United States